In the context of real-world evidence, a registry is a collection of data on a particular disease, medical condition, or treatment that is recorded over time. A registry-based study, on the other hand, is a research study that uses data from a registry to evaluate the safety or effectiveness of a particular treatment or medical intervention.
A registry is typically created to collect data on a particular population, such as patients with a specific medical condition or those who have been treated with a particular medication. The data collected in a registry may be observational or experimental, and can include demographic information, medical history, treatment information, and outcomes.
A registry-based study, on the other hand, is a research study that uses data from a registry to evaluate the safety or effectiveness of a particular treatment or medical intervention. In a registry-based study, researchers analyze the data collected in a registry to answer specific research questions, such as whether a particular treatment is effective in improving patient outcomes, or whether there are any safety concerns associated with a specific medication.
The main difference between a registry and a registry-based study is that a registry is a database of information, while a registry-based study is a research study that uses data from a registry. Registries can be used for a variety of purposes, including monitoring the safety and effectiveness of treatments, tracking disease incidence and prevalence, and identifying gaps in care. Registry-based studies are one way to use the data collected in a registry to generate new knowledge and insights about a particular disease or treatment.
Overall, both registries and registry-based studies are important tools for collecting and analyzing real-world evidence, and can provide valuable information to healthcare providers, patients, and researchers about the safety and effectiveness of medical interventions.
Share this story...
Real World Evidence (RWE) 101 – Data Tokenization
RWE 101 - 4 Potential Uses for Improving Drug Development Real world evidence (RWE) refers to data collected outside the context of traditional clinical trials, such as [...]
Real World Evidence (RWE) 101 – Primary Data versus Secondary Data
RWE 101 - Primary Data versus Secondary Data Primary data and secondary data are two types of data used in research. The main difference between the two [...]
RWE 101 – Secondary Use of Existing Data
RWE 101 - Secondary Use of Existing Data Secondary use of existing data refers to the practice of analyzing data that was collected for a different purpose [...]
RWE 101 – Why is there so much excitement about the use of AI in the context of real world evidence?
RWE 101 - Why is there so much excitement about the use of AI in the context of real world evidence? The use of Artificial Intelligence (AI) [...]
RWE 101 – What is the Difference Between an IRB and a REC?
RWE 101 - What is the Difference Between an IRB and a REC? An Institutional Review Board (IRB) and a Research Ethics Committee (REC) are two different [...]
RWE 101 – Do I Need IRB Approval for My Observational Study?
RWE 101 - Do I Need IRB Approval for My Observational Study? In general, observational studies that involve human subjects require Institutional Review Board (IRB) approval to [...]







